395 related articles for article (PubMed ID: 20460924)
1. Hepatitis C virus, diabetes and steatosis: clinical evidence in favor of a linkage and role of genotypes.
Mihm S
Dig Dis; 2010; 28(1):280-4. PubMed ID: 20460924
[TBL] [Abstract][Full Text] [Related]
2. Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C.
Castera L
Minerva Gastroenterol Dietol; 2006 Jun; 52(2):125-34. PubMed ID: 16557184
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
Serfaty L; Capeau J
Liver Int; 2009 Mar; 29 Suppl 2():13-25. PubMed ID: 19187069
[TBL] [Abstract][Full Text] [Related]
4. Review article: hepatitis C virus-associated steatosis--pathogenic mechanisms and clinical implications.
Adinolfi LE; Durante-Mangoni E; Zampino R; Ruggiero G
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():52-5. PubMed ID: 16225474
[TBL] [Abstract][Full Text] [Related]
5. Hepatic steatosis and hepatitis C: Still unhappy bedfellows?
Hwang SJ; Lee SD
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():96-101. PubMed ID: 21199519
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C and steatosis.
Björnsson E; Angulo P
Arch Med Res; 2007 Aug; 38(6):621-7. PubMed ID: 17613353
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
[TBL] [Abstract][Full Text] [Related]
8. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
[TBL] [Abstract][Full Text] [Related]
9. Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C.
Tachi Y; Katano Y; Honda T; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Samejima Y; Goto H
Liver Int; 2010 Apr; 30(4):554-9. PubMed ID: 19951380
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C and steatosis.
Monto A
Semin Gastrointest Dis; 2002 Jan; 13(1):40-6. PubMed ID: 11944633
[TBL] [Abstract][Full Text] [Related]
11. Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C.
Liu CJ; Jeng YM; Chen PJ; Lai MY; Yang HC; Huang WL; Kao JH; Chen DS
Antivir Ther; 2005; 10(3):405-15. PubMed ID: 15918331
[TBL] [Abstract][Full Text] [Related]
12. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.
Durante-Mangoni E; Zampino R; Marrone A; Tripodi MF; Rinaldi L; Restivo L; Cioffi M; Ruggiero G; Adinolfi LE
Aliment Pharmacol Ther; 2006 Nov; 24(9):1349-57. PubMed ID: 17059516
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients.
Imazeki F; Yokosuka O; Fukai K; Kanda T; Kojima H; Saisho H
Liver Int; 2008 Mar; 28(3):355-62. PubMed ID: 18290778
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.
Cammà C; Bruno S; Di Marco V; Di Bona D; Rumi M; Vinci M; Rebucci C; Cividini A; Pizzolanti G; Minola E; Mondelli MU; Colombo M; Pinzello G; Craxì A
Hepatology; 2006 Jan; 43(1):64-71. PubMed ID: 16374856
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C and steatosis: a reappraisal.
Lonardo A; Loria P; Adinolfi LE; Carulli N; Ruggiero G
J Viral Hepat; 2006 Feb; 13(2):73-80. PubMed ID: 16436124
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease and hepatitis C infection.
Bondini S; Younossi ZM
Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
[TBL] [Abstract][Full Text] [Related]
17. Metabolic aspects of hepatitis C viral infection: steatohepatitis resembling but distinct from NASH.
Koike K; Moriya K
J Gastroenterol; 2005 Apr; 40(4):329-36. PubMed ID: 15868369
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C and diabetes: the inevitable coincidence?
Lonardo A; Adinolfi LE; Petta S; Craxì A; Loria P
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):293-308. PubMed ID: 19344243
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance and response to antiviral therapy in chronic hepatitis C: mechanisms and management.
del Campo JA; López RA; Romero-Gómez M
Dig Dis; 2010; 28(1):285-93. PubMed ID: 20460925
[TBL] [Abstract][Full Text] [Related]
20. Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C.
Antúnez I; Aponte N; Fernández-Carbia A; Rodríguez-Perez F; Toro DH
P R Health Sci J; 2004 Jun; 23(2 Suppl):57-60. PubMed ID: 16929588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
